Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA

Overview of attention for article published in Respiratory Research, July 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 2 news outlets
twitter: 18 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 67 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Interasma, 21 Aug 2019

Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.